Gene expression in distinct regions of the heart

Lancet

Volumn 355, Issue 9208, 2000, Pages 979-983

  Thum, Thomas ^a   Borlak, Jürgen ^a  

^a FRAUNHOFER INSTITUTE FOR TOXICOLOGY AND EXPERIMENTAL MEDICINE   (Germany)

Author keywords

[No Author keywords available]

Indexed keywords

BETA ADRENERGIC RECEPTOR BLOCKING AGENT; CYTOCHROME P450; DIMETHYLANILINE MONOOXYGENASE; DRUG METABOLIZING ENZYME; EPOXIDE HYDROLASE; HEART ENZYME; MESSENGER RNA; UNSPECIFIC MONOOXYGENASE; VERAPAMIL;

ARTERIAL TRUNK; ARTICLE; CLINICAL ARTICLE; CONTROLLED STUDY; DRUG METABOLISM; ENZYME ACTIVITY; FEMALE; GENE EXPRESSION; HEART DILATATION; HEART RIGHT VENTRICLE; HUMAN; HUMAN TISSUE; MALE; PRIORITY JOURNAL; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; TISSUE SPECIFICITY;

EID: 0034681831     PISSN: 01406736     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0140-6736(00)99016-0     Document Type: Article

References (20)

1. Smith G., Stubbins M.J., Harries L.W., Wolf C.R. Molecular genetics of the human cytochrome P450 monooxygenase superfamily. Xenobiotica. 28:1998;1129-1165.
2. Raunio H., Pasanen M., Maenpaa J., Hakkola J., Pelkonen O. Expression of extrahepatic cytochrome P450 in humans. Pacifici G.M., Fracchia G.N. Advances in drug metabolism in man. 1995;233-288 European Commission, Luxembourg.
3. Kivisto K.T., Griese E.U., Fritz P.et al. Expression of cytochrome P450 3A enzymes in human lung. a combined RT-PCR and immunohistochemical analysis of normal tissue and lung tumours Arch Pharmacol. 353:1996;207-212.
4. Oldham H.G., Clarke S.E. In vitro identification of the human cytochrome P450 enzymes involved in the metabolism of R(+) and S(-)-carvedilol. Drug Metab Dispos. 25:1997;970-977.
5. Tracy T.S., Korzekwa K.R., Gonzalez F.J., Wainer I.W. Cytochrome P450 isoforms involved in metabolism of the enantiomers of verapamil and norverapamil. Br J Clin Pharmacol. 47:1999;545-552.
6. Jurima-Romet M., Huang H.S. Comparative cytotoxicity of angiotensin-converting enzyme inhibitors in cultured rat hepatocytes. Biochem Pharmacol. 46:1993;2163-2170.
7. Stearns R.A., Chakravarty P.K., Chen R., Chiu S.H. Biotransformation of losartan to its active carboxylic acid metabolite in human liver microsomes. role of cytochrome P4502C and 3A subfamily members Drug Metab Dispos. 23:1995;207-215.
8. Aristizabal D., Messerli F.H., Froehlich E.D. Disparate structural effect on left and right ventricles by angiotensin-converting enzyme inhibitors and calcium antagonists in essential hypertension. Am J Cardiol. 73:1994;483-487.
9. Zierhut W., Zimmer H.G., Gerdes A.M. Influence of ramipril on right ventricular hypertrophy induced by pulmonary artery stenosis in rats. J Cardiovasc Pharmacol. 16:1990;480-486.
10. Hakkola J., Pasanen M., Purkunen R.et al. Expression of xenobiotic-metabolizing cytochrome P450 forms in human adult and fetal liver. Biochem Pharmacol. 48:1994;59-64.
11. Altschul S.F. Gapped BLAST and PSI-BLAST. a new generation of protein database search programmes Nucl Acids Res. 25:1997;3389-3402.
12. Smith P.K., Krohn R.I., Hermanson G.T.et al. Measurement of protein using bicinchoninic acid. Anal Biochem. 150:1985;76-85.
13. Cheng Y.F., Neue U.D., Bean L. Straightforward solid-phase extraction method for the determination of verapamil and its metabolite in plasma in a 96-well extraction plate. J Chromatogr A. 828:1999;273-281.
14. Borlak J., Harsany V., Schneble H., Haegele K.D. PNAT and cytochrome P2D6 gene polymorphism in epileptic patients. Biochem Pharmacol. 48:1994;1717-1720.
15. Smith D.A., Abel S.M., Hyland R., Jones B.C. Human cytochrome P450s. selectivity and measurement in vivo Xenobiotica. 28:1998;1095-1128.
16. Clarke S.E. In vitro assessment of human cytochrome P450. Xenobiotica. 28:1998;1167-1202.
17. Price T., Aitken J., Simpson E.R. Relative expression of aromatase cytochrome P450 in human fetal tissues as determined by competitive polymerase chain reaction amplification. J Clin Endocrinol Metab. 74:1992;879-883.
18. Wu S., Moomaw C.R., Tomer K.B., Falck J.R., Zeldin D.C. Molecular cloning and expression of cytochrome P2J2, a human cytochrome P450 arachidonic acid epoxygenase highly expressed in heart. J Biol Chem. 271:1996;3460-3468.
19. McCallum G.P., Horton J.E., Falkner K.C., Bend J.R. Microsomal cytochrome P4501A1 dependent monooxygenase activity in guinea pig heart. induction, inhibition, and increased activity by addition of exogenous NADPH-cytochrome P450 reductase Can J Physiol Pharmacol. 71:1993;151-156.
20. 2+ channels and contraction in mammalian heart cells J Physiol (Lond). 508:1998;777-792.